THYROID EYE DISEASE, TED
Clinical trials for THYROID EYE DISEASE, TED explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE, TED trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE, TED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for thyroid eye disease: drug may beat steroids after emergency surgery
Disease control Not yet recruitingThis study tests a new drug called teprotumumab against standard steroid treatment in 60 adults with severe thyroid eye disease causing vision loss. All participants will first have emergency eye surgery, then receive either teprotumumab or steroids for 24 weeks. The goal is to s…
Matched conditions: THYROID EYE DISEASE, TED
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Could fewer infusions tame thyroid eye disease just as well?
Disease control Not yet recruitingThis study compares a shortened 4-infusion course of the drug Teprotumumab (Tepezza) to the standard 8-infusion course in people with active thyroid eye disease (TED). The goal is to see if those who respond well early can safely stop treatment sooner with the same benefits. The …
Matched conditions: THYROID EYE DISEASE, TED
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New injection aims to reduce bulging eyes in thyroid disease
Disease control Not yet recruitingThis study tests a new medicine called KRIYA-586 (VV-14305) given as an injection around the eye for people with moderate to severe thyroid eye disease. The goal is to see if it is safe and can reduce eye bulging better than a sham procedure. About 110 adults aged 18 to 80 will t…
Matched conditions: THYROID EYE DISEASE, TED
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC